From: Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
Fatty Acids (g/100Â g) | Controls | Patients |
---|---|---|
C-14:0 | 1.29 ± 0.7 | 1.34 ± 0.9 |
C-16 : 0 | 19.84 ± 3.2 | 24.63 ± 5.1* |
C-18 : 0 | 14.30 ± 5.6 | 17.80 ± 6.9 |
C-20 : 0 | 0.82 ± 0.5 | 0.16 ± 0.3* |
C-24 : 0 | 0.11 ± 0.1 | 0.009 ± 0.03 |
C-14 : 1 | 0.14 ± 0.2 | 0.45 ± 0.4* |
C-16 : 1 | 2.25 ± 0.8 | 3.58 ± 1.1* |
C-18 : 1 | 22.50 ± 5.1 | 24.36 ± 3.1 |
C-22 : 1 | 1.70 ± 0.8 | 0.88 ± 0.6* |
C-24 : 1 | ND | ND |
C-18 : 2 | 27.99 ± 3.9 | 20.48 ± 3.8* |
C-18 : 3 | 0.29 ± 0.1 | 0.07 ± 0.1 |
C-20 : 3 | 0.61 ± 0.4 | 0.18 ± 0.3 |
C-20 : 4 | 5.40 ± 2.4 | 2.55 ± 1.2* |
C-20 : 5 | 0.54 ± 0.1 | ND* |
C-22 : 5 | 0.05 ± 0.1 | 0.12 ± 0.1 |
C-22 : 6 | 0.09 ± 0.2 | 0.33 ± 0.4* |